Organic cation transporters in intestine, kidney, liver, and brain

Annual Review of Physiology
H Koepsell

Abstract

This review focuses on sodium-independent transport systems for organic cations in small intestine, liver, kidney, and brain. The roles of P-glycoproteins (MDR) and anion transporters (OATP) in organic cation transport are reported, and two members of the new transporter family OCT are described. The OCT transporters belong to a superfamily that includes multidrug-resistance proteins, facilitative diffusion systems, and proton antiporters. They mediate electrogenic transport of small organic cations with different molecular structures, independently of sodium and proton gradients. The current knowledge of the distribution and functional properties of cloned cation transport systems and of cation transport measured in intact plasma membranes is used to postulate identical or homologous transporters in intestine, liver, kidney, and brain.

References

Jan 15, 1977·Biochemical Pharmacology·K Turnheim, F O Lauterbach
Feb 1, 1978·Journal of Neurochemistry·E M CornfordW H Oldendorf
Oct 1, 1975·Journal of Neurochemistry·P T Carroll, A M Goldberg
Sep 1, 1992·Journal of Neurochemistry·E Galea, C Estrada
Sep 1, 1992·Gastroenterology·R H MoseleyP A Permoad
Mar 23, 1992·Biochimica Et Biophysica Acta·M KobayashiK Miyazaki
Sep 10, 1991·Biochimica Et Biophysica Acta·K IsekiK Miyazaki
Nov 1, 1990·Pflügers Archiv : European journal of physiology·C Bevan, R K Kinne
Feb 1, 1987·The American Journal of Physiology·L C McKinney, R W Ratzlaff
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F ThiebautM C Willingham
Mar 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·U Trendelenburg
May 1, 1989·Journal of Neuroscience Research·I A Paterson, L Hertz
Jan 1, 1987·CRC Critical Reviews in Biochemistry·B I Kanner, S Schuldiner
Mar 1, 1989·The American Journal of Physiology·B RajuR E London
Apr 1, 1988·The Journal of Physiology·D CasirolaG Rindi
Nov 1, 1973·The American Journal of Physiology·M Acara, B Rennick
Dec 1, 1973·Journal of Neurochemistry·H I Yamamura, S H Snyder
Nov 10, 1972·Science·H I Yamamura, S H Snyder
Jan 1, 1970·European Journal of Pharmacology·D K MeijerK J van der Laan
Nov 21, 1984·Biochimica Et Biophysica Acta·K Yoshioka
Jan 1, 1984·Annual Review of Biochemistry·C W Tabor, H Tabor
Jun 1, 1982·The Journal of Physiology·J GreenwoodO E Pratt

❮ Previous
Next ❯

Citations

May 10, 2006·Archives of Pharmacal Research·Soon-Sun HongChang-Koo Shim
Aug 15, 2006·Archives of Pharmacal Research·Moon Kyoung Kim, Chang-Koo Shim
Mar 16, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Franziska StellmerChris Mühlhausen
Jan 22, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Fatma Al-SaeediTim A D Smith
Feb 3, 2005·Pflügers Archiv : European journal of physiology·Giuliano Ciarimboli, Eberhard Schlatter
Mar 13, 2009·Journal of Neural Transmission·Thomas WultschAndreas Reif
Sep 29, 2012·Molecular Diagnosis & Therapy·Gaia Chiara Mannino, Giorgio Sesti
Feb 6, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Franziska GrafeMatthias Brandsch
Oct 9, 2002·Toxicon : Official Journal of the International Society on Toxinology·Darío AndrinoloNéstor Lagos
Sep 17, 1999·Journal of Hepatology·G A Kullak-Ublick
Sep 29, 2001·Advanced Drug Delivery Reviews·D WagnerP Langguth
Jun 6, 2000·Advanced Drug Delivery Reviews·V GanapathyF H Leibach
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·G J HooiveldM Müller
May 6, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Helena EngmanHans Lennernäs
Oct 26, 2001·Drug Discovery Today·Robert A. ColemanAnthony M. Brown
May 3, 2000·Kidney International·G GastaldiG Rindi
Sep 6, 2000·Kidney International·K I InuiH Saito
Aug 30, 2000·Proceedings of the Society for Experimental Biology and Medicine·G Rindi, U Laforenza
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Frank LammertBeverly Paigen
Jul 26, 2005·Pharmacogenetics and Genomics·Sara ColomboUNKNOWN Swiss HIV Cohort Study
Jun 30, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mingyan ZhouJoanne Wang
May 4, 2004·Molecular and Cellular Biology·Hui QuanMarc G Caron
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Wooin Lee, Richard B Kim
Mar 24, 2006·Nephron. Physiology·Vincent Launay-VacherGilbert Deray
Nov 28, 2002·Journal of Dental Research·Q YangJ D Walters
Sep 2, 2006·Biological & Pharmaceutical Bulletin·Masuo KondohYoshiteru Watanabe
Jun 2, 2009·Biological & Pharmaceutical Bulletin·Paranee MeetamVaranuj Chatsudthipong
Nov 21, 2002·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yumiko Urakami
Dec 20, 2003·Pharmacogenomics·Toshihisa IshikawaYasuhiro Sumino

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
transfection

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.